Chapel Hill, NC, United States of America

Jill Marie Sturdivant

USPTO Granted Patents = 55 (Patent Applications = 21)

CIPO Patents = 6 (Patent Applications = 9)

EPO Patents = 13 (Patent Applications = 22)

Average Co-Inventor Count = 3.6

ph-index = 18

Forward Citations = 875(Granted Patents)

DiyaCoin

= 0.04

Inventors with similar research interests:

Company Filing History:

52 out of 60

Aerie Pharmaceuticals, Inc.

patents

2 out of 4

Novaer Holdings, Inc.

The Johns Hopkins University

patents

where one patent can have more than one assignee

Years Active: 2010-2024

where 'Filed Patents' based on already Granted Patents

55 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12018012 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2024-06-25),

2. 11891376 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2024-02-06),

3. 11707460 - Ophthalmic compositions (2023-07-25),

4. 11691950 - Isoquinoline-steroid conjugates and uses thereof (2023-07-04),

5. 11618748 - Dual mechanism inhibitors for the treatment of disease (2023-04-04),

6. 11590123 - Ophthalmic compositions (2023-02-28),

7. 11427563 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2022-08-30),

8. 11389441 - Ophthalmic compositions (2022-07-19),

9. 11312700 - Aryl cyclopropyl-amino-isoquinolinyl amide compounds (2022-04-26),

10. 11197853 - Combination therapy (2021-12-14),

11. 11185538 - Compositions for treating glaucoma or reducing intraocular pressure (2021-11-30),

12. 11117869 - Compounds, compositions and methods for treatment of myopia (2021-09-14),

13. 11059789 - Isoquinoline-steroid conjugates and uses thereof (2021-07-13),

14. 11028081 - Dual mechanism inhibitors for the treatment of disease (2021-06-08),

15. 11021456 - Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds (2021-06-01),

Sure, here is the article about inventor Jill Marie Sturdivant based on the information provided:

Title: The Innovative Works of Inventor Jill Marie Sturdivant

Introduction:

Jill Marie Sturdivant is a prolific inventor based in Chapel Hill, NC, with an impressive portfolio of 54 patents to his name. His groundbreaking work has made significant contributions to the fields of ophthalmology, cardiovascular health, anti-inflammatory treatments, and oncology.

Latest Patents:

Among his latest patents is the development of Aryl cyclopropyl-amino-isoquinolinyl amide compounds. These compounds have shown promise in the treatment of various eye diseases such as glaucoma and retinal diseases, as well as in the management of cardiovascular conditions and abnormal cell growth, particularly in cancer treatment. Additionally, his ophthalmic compositions have garnered attention for their potential therapeutic applications.

Career Highlights:

Throughout his career, Jill Marie Sturdivant has made significant strides in the pharmaceutical industry. He has held key positions at leading companies such as Aerie Pharmaceuticals, Inc. and Novaer Holdings, Inc., where his innovative research and development have led to groundbreaking patents and advancements in healthcare.

Collaborations:

Jill Marie Sturdivant has collaborated with esteemed professionals in the field, including coworkers like Mitchell Anthony deLong and Susan Marie Royalty. Together, they have worked on projects that have pushed the boundaries of science and technology, leading to novel solutions for complex medical challenges.

Conclusion:

In conclusion, Jill Marie Sturdivant stands as a pioneering inventor whose work has had a profound impact on the healthcare industry. His patents and innovations continue to inspire new developments and pave the way for improved treatments and therapies. Through his dedication and expertise, he has established himself as a leader in the field of pharmaceutical research and development.

I hope you find this information helpful. If you need further details or have any other requests, feel free to let me know!

This text is generated by artificial intelligence and may not be accurate.